Coronavirus Update: South Korea's Celltrion Progresses Antibody, Yancopoulos: 'The World Is Counting On Us'

Antibody Therapies Could Ease Huge Burden On Emergency Care

 
• By Scrip Team

Regeneron's head of R&D George Yancopoulos delivers some stirring words about the need to unify against the global threat posed by COVID-19.  

Seoul_Tower
Seoul, South Korea: The country has been the most successful in curbing the spread of the disease, and now its companies are joining efforts to develop therapies and diagnostics

More from COVID-19

More from Scrip